| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 45.26B | 45.42B | 42.79B | 49.60B | 35.41B | 28.98B |
| Gross Profit | 9.84B | 9.63B | 8.26B | 9.41B | 8.05B | 6.93B |
| EBITDA | 6.89B | 6.53B | 5.50B | 6.67B | 5.18B | 4.32B |
| Net Income | 3.44B | 3.13B | 2.38B | 3.23B | 2.54B | 2.00B |
Balance Sheet | ||||||
| Total Assets | 45.72B | 46.85B | 45.03B | 48.16B | 42.35B | 37.24B |
| Cash, Cash Equivalents and Short-Term Investments | 4.64B | 5.05B | 3.40B | 4.94B | 3.54B | 3.41B |
| Total Debt | 8.20B | 8.47B | 9.02B | 12.27B | 11.26B | 10.23B |
| Total Liabilities | 17.90B | 18.97B | 20.06B | 24.91B | 22.05B | 19.51B |
| Stockholders Equity | 27.82B | 27.88B | 24.97B | 23.13B | 20.21B | 17.65B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.17B | 3.99B | 1.12B | -434.00M | 625.00M |
| Operating Cash Flow | 0.00 | 5.04B | 4.97B | 2.04B | 2.00B | 2.37B |
| Investing Cash Flow | 0.00 | -1.83B | -1.89B | -961.00M | -2.32B | -1.86B |
| Financing Cash Flow | 0.00 | -1.64B | -4.74B | 245.00M | 308.00M | -1.82B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥121.87B | 10.07 | ― | 3.72% | 5.40% | 14.80% | |
76 Outperform | ¥81.58B | 6.04 | ― | 3.04% | 1.57% | -33.97% | |
76 Outperform | ¥91.42B | 7.61 | ― | 3.02% | 1.66% | 11.28% | |
75 Outperform | ¥80.67B | 19.80 | ― | 1.12% | 3.77% | 7.65% | |
67 Neutral | ¥65.92B | 10.30 | ― | 2.22% | 5.17% | 79.36% | |
62 Neutral | ¥97.13B | 19.44 | ― | 1.30% | 47.56% | 49.58% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |